Literature DB >> 34863832

Characterizing of a new α-agarase AgaE from Thalassomonas sp. LD5 and probing its catalytically essential residues.

Jingnan Xu1, Zibo Cui1, Weibin Zhang1, Jingxuan Lu1, Xinzhi Lu2, Wengong Yu3.   

Abstract

A new α-agarase AgaE belonging to glycoside hydrolase (GH) family 96 was identified and cloned from marine bacterium Thalassomonas sp. LD5. AgaE consists of 926 amino acids with a theoretical molecular mass of 97 kDa. The optimum temperature and pH for recombinant AgaE were 35 °C and 7.0, respectively. In contrast to known α-agarases, the activity of AgaE does not depend on Ca2+, but on Na+. Thin-layer chromatography and 13C NMR analysis revealed that AgaE endohydrolytic of agarose to produce agarotetraose and agarohexaose as the final main products. Extensive site-directed mutagenesis studies on the conserved carboxylic amino acids of GH96 revealed two essential amino acids for AgaE, D779 and D781. Replacing D779 with G779 leads to complete inactivation of the enzyme, while D781G results in 70% loss of activity. Later studies showed that site D781 involved in the binding of Na+, and its mutation raised the optimal concentration of Na+ 4 times higher than that of the wild type. However, attempts to rescue the mutant's activities with sodium azide were failed. Kinetic parameters comparison of AgaE, AgaD, another α-agarase from LD5, and their mutants revealed that the former aspartic acid plays critical role in the catalysis.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Catalytic residue; Site-directed mutation; α-Agarase

Mesh:

Substances:

Year:  2021        PMID: 34863832     DOI: 10.1016/j.ijbiomac.2021.11.194

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Biochemical Properties of a New Polysaccharide Lyase Family 25 Ulvan Lyase TsUly25B from Marine Bacterium Thalassomonas sp. LD5.

Authors:  Danni Wang; Yujiao Li; Lu Han; Chengying Yin; Yongqing Fu; Qi Zhang; Xia Zhao; Guoyun Li; Feng Han; Wengong Yu
Journal:  Mar Drugs       Date:  2022-02-25       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.